Luliporus Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including dermatophytosis, tinea versicolor, and candidiasis. Luliconazole belongs to the azole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted application, promoting rapid relief of symptoms such as itching, redness, and scaling associated with fungal infections. Luliporus Cream is generally well tolerated, with minimal local adverse effects such as mild burning or irritation at the site of application. It is recommended to apply a thin layer of the cream to the affected area once daily, preferably after cleansing, and to continue treatment for the full prescribed duration to prevent recurrence. Caution is advised in patients with known hypersensitivity to luliconazole or any cream excipients. The product is not intended for use in mucosal areas, eyes, or open wounds. Luliporus Cream offers an effective therapeutic option for managing common superficial fungal infections, improving patient comfort and skin health when used as directed.